These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22996811)

  • 21. Antileishmanial sesquiterpene lactones from Pseudelephantopus spicatus, a traditional remedy from the Chayahuita Amerindians (Peru). Part III.
    Odonne G; Herbette G; Eparvier V; Bourdy G; Rojas R; Sauvain M; Stien D
    J Ethnopharmacol; 2011 Sep; 137(1):875-9. PubMed ID: 21771652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi.
    Canto-Cavalheiro MM; Echevarria A; Araujo CA; Bravo MF; Santos LH; Jansen AM; Leon LL
    Microbios; 1997; 90(362):51-60. PubMed ID: 9301071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel dialkylphosphorylhydrazones: Synthesis, leishmanicidal evaluation and theoretical investigation of the proposed mechanism of action.
    da Matta CB; de Queiroz AC; Santos MS; Alexandre-Moreira MS; Gonçalves VT; Del Cistia Cde N; Sant'Anna CM; DaCosta JB
    Eur J Med Chem; 2015 Aug; 101():1-12. PubMed ID: 26107111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
    Reimão JQ; Scotti MT; Tempone AG
    Bioorg Med Chem; 2010 Nov; 18(22):8044-53. PubMed ID: 20934347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives.
    Calogeropoulou T; Angelou P; Detsi A; Fragiadaki I; Scoulica E
    J Med Chem; 2008 Feb; 51(4):897-908. PubMed ID: 18220332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids.
    Kapou A; Benetis NP; Avlonitis N; Calogeropoulou T; Koufaki M; Scoulica E; Nikolaropoulos SS; Mavromoustakos T
    Bioorg Med Chem; 2007 Feb; 15(3):1252-65. PubMed ID: 17158053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
    Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
    Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, antileishmanial activity and structure-activity relationship of 1-N-X-phenyl-3-N'-Y-phenyl-benzamidines.
    Rodrigues-Santos CE; Leon LL; Bortoluzzi AJ; Canto-Cavalheiro MM; Machado GC; Echevarria A
    Eur J Med Chem; 2013 Sep; 67():166-74. PubMed ID: 23851118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Biological Activity, and Mechanism of Action of 2-Pyrazyl and Pyridylhydrazone Derivatives, New Classes of Antileishmanial Agents.
    Coimbra ES; Antinarelli LMR; de A Crispi M; Nogueira TCM; Pinheiro AC; de Souza MVN
    ChemMedChem; 2018 Jul; 13(14):1387-1394. PubMed ID: 29790287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and activity of novel tetrazole compounds and their pyrazole-4-carbonitrile precursors against Leishmania spp.
    Faria JV; dos Santos MS; Bernardino AM; Becker KM; Machado GM; Rodrigues RF; Canto-Cavalheiro MM; Leon LL
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6310-2. PubMed ID: 24125880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial, antileishmanial and cytotoxic compounds from Piper chaba.
    Naz T; Mosaddik A; Rahman M; Muhammad I; Haque E; Cho SK
    Nat Prod Res; 2012; 26(11):979-86. PubMed ID: 21834629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae).
    Grecco Sdos S; Reimão JQ; Tempone AG; Sartorelli P; Cunha RL; Romoff P; Ferreira MJ; Fávero OA; Lago JH
    Exp Parasitol; 2012 Feb; 130(2):141-5. PubMed ID: 22143090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation.
    Rodrigues RF; da Silva EF; Echevarria A; Fajardo-Bonin R; Amaral VF; Leon LL; Canto-Cavalheiro MM
    Eur J Med Chem; 2007 Jul; 42(7):1039-43. PubMed ID: 17367894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure-activity relationship (SAR).
    Bello ML; Chiaradia LD; Dias LR; Pacheco LK; Stumpf TR; Mascarello A; Steindel M; Yunes RA; Castro HC; Nunes RJ; Rodrigues CR
    Bioorg Med Chem; 2011 Aug; 19(16):5046-52. PubMed ID: 21757358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and antileishmanial in vitro activity of new series of chalcones-like compounds: a molecular hybridization approach.
    Barbosa TP; Sousa SC; Amorim FM; Rodrigues YK; de Assis PA; Caldas JP; Oliveira MR; Vasconcellos ML
    Bioorg Med Chem; 2011 Jul; 19(14):4250-6. PubMed ID: 21684751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives.
    dos Santos MS; Oliveira ML; Bernardino AM; de Léo RM; Amaral VF; de Carvalho FT; Leon LL; Canto-Cavalheiro MM
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7451-4. PubMed ID: 22055204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeic acid esters and lignans from Piper sanguineispicum.
    Cabanillas BJ; Le Lamer AC; Castillo D; Arevalo J; Rojas R; Odonne G; Bourdy G; Moukarzel B; Sauvain M; Fabre N
    J Nat Prod; 2010 Nov; 73(11):1884-90. PubMed ID: 20954722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
    Bhattacharya G; Herman J; Delfín D; Salem MM; Barszcz T; Mollet M; Riccio G; Brun R; Werbovetz KA
    J Med Chem; 2004 Mar; 47(7):1823-32. PubMed ID: 15027874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileishmanial ring-substituted ether phospholipids.
    Avlonitis N; Lekka E; Detsi A; Koufaki M; Calogeropoulou T; Scoulica E; Siapi E; Kyrikou I; Mavromoustakos T; Tsotinis A; Grdadolnik SG; Makriyannis A
    J Med Chem; 2003 Feb; 46(5):755-67. PubMed ID: 12593656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.